Prognostic significance of systemic inflammatory markers in esophageal cancer: Systematic review and meta-analysis

45Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aim: Impact of several immune-inflammatory markers on long-term outcome has been reported in various malignancies. The aim of the present study was to evaluate through a meta-analysis the oncological outcome of immune-inflammatory markers, such as neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and C-reactive protein to albumin ratio (CAR) in esophageal cancer. Methods: A systematic electronic search for relevant studies was carried out in PubMed, Cochrane library, Embase, and Google scholar. Meta-analysis was done using hazard ratio (HR) and 95% confidence interval (CI) as effect measures. A systematic review and meta-analysis were undertaken according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol. P-values

Cite

CITATION STYLE

APA

Ishibashi, Y., Tsujimoto, H., Yaguchi, Y., Kishi, Y., & Ueno, H. (2020, January 1). Prognostic significance of systemic inflammatory markers in esophageal cancer: Systematic review and meta-analysis. Annals of Gastroenterological Surgery. Wiley-Blackwell Publishing Ltd. https://doi.org/10.1002/ags3.12294

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free